NCT00416793
Bortezomib and Carboplatin in Treating Patients With Metastatic Pancreatic Cancer treatment 2 terminated NCT00085371
Triapine as First-Line or Second-Line Therapy in Treating Patients With Locally Advanced or Metastatic Cancer of the Pancreas treatment 2 completed NCT01537107
Sirolimus and Vismodegib in Treating Patients With Solid Tumors or Pancreatic Cancer That is Metastatic or Cannot Be Removed By Surgery treatment 1 completed NCT00031694
Paclitaxel and Bryostatin 1 in Treating Patients With Advanced Pancreatic Cancer treatment 2 completed NCT01893294
Gemcitabine Hydrochloride in Treating Patients With Locally Advanced Pancreatic Cancer treatment 1 completed NCT01473940
Ipilimumab and Gemcitabine Hydrochloride in Treating Patients With Stage III-IV or Recurrent Pancreatic Cancer That Cannot Be Removed by Surgery treatment 1 completed NCT01839981
CPI-613 in Treating Patients With Locally Advanced or Metastatic Pancreatic Cancer treatment 1 completed NCT02048943
Dovitinib Lactate, Gemcitabine Hydrochloride, and Paclitaxel Albumin-Stabilized Nanoparticle Formulation in Treating Patients With Advanced Solid Tumors or Pancreatic Cancer treatment 1 withdrawn NCT00397787
Sunitinib in Treating Patients With Metastatic Pancreatic Cancer That Progressed After First-Line Therapy With Gemcitabine treatment 2 completed NCT01741597
Dynamic Contrast Enhanced MRI in Patients With Advanced Breast or Pancreatic Cancer With Metastases to the Liver or Lung diagnostic 1 withdrawn NCT01770132
Ultrasound-Guided Photodynamic Therapy With Photofrin & Gemcitabine for Patients With Locally Advanced Pancreatic Cancer treatment 1 completed NCT01643499
Genotype-guided Dosing of mFOLFIRINOX Chemotherapy in Patients With Previously Untreated Advanced Gastrointestinal Malignancies treatment 1 completed NCT02178436
Gemcitabine, Nab-paclitaxel and KPT-330 in Advanced Pancreatic Cancer treatment 1 / 2 completed NCT01835041
CPI-613 and Combination Chemotherapy in Treating Patients With Metastatic Pancreatic Cancer treatment 1 completed NCT01234935
Dasatinib and Gemcitabine Hydrochloride or Gemcitabine Hydrochloride Alone in Treating Patients With Pancreatic Cancer Previously Treated With Surgery treatment 2 completed NCT01739439
Chemoradiation and Radiosurgery Boost in Treating Patients With Locally Advance Pancreatic Cancer That May or May Not be Removed by Surgery treatment 1 terminated NCT01666730
Metformin Plus Modified FOLFOX 6 in Metastatic Pancreatic Cancer treatment 2 completed NCT02047474
Combination Chemotherapy Before and After Surgery in Treating Patients With Localized Pancreatic Cancer treatment 2 active_not_recruiting NCT01924260
Alisertib and Gemcitabine Hydrochloride in Treating Patients With Solid Tumors or Pancreatic Cancer treatment 1 completed NCT00981162
Sorafenib Tosylate and Everolimus in Treating Patients With Advanced Solid Tumors and Metastatic Pancreatic Cancer That Does Not Respond to Gemcitabine Hydrochloride treatment 1 completed NCT00052689
Bortezomib With or Without Gemcitabine in Treating Patients With Metastatic Pancreatic Cancer treatment 2 completed NCT01821612
Chemotherapy and Radiation Therapy Before Surgery Followed by Gemcitabine in Treating Patients With Pancreatic Cancer treatment 0 completed NCT02153450
Stereotactic Radiosurgery and Metformin in Patients With Borderline-Resectable or Locally-Advanced Pancreatic Cancer treatment 0 completed